EMEA-002644-PIP01-19-M01
Key facts
| Active substance |
Cyclophosphamide
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0490/2021
|
| PIP number |
EMEA-002644-PIP01-19-M01
|
| Pharmaceutical form(s) |
Powder for oral solution
|
| Condition(s) / indication(s) |
Treatment of all malignant neoplasms
|
| Route(s) of administration |
|
| Contact for public enquiries |
Accord Healthcare S.L.U.
E-mail: regulatory_EU@accord-healthcare.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|